Home » hepatitis c virus » Recent Articles:

Cirrhosis Causes

March 10, 2010 Liver Disease No Comments

Several processes can lead to cirrhosis.

Alcoholism

Alcoholism particularly endangers the liver. Alcoholic cirrhosis (also sometimes referred to as portal, Laennec’s, nutritional, or micronodular cirrhosis) is the primary cause of cirrhosis in the U.S. It is estimated to be responsible for 44% of deaths from cirrhosis in North America. Some experts believe this estimate is low. One Canadian study found alcohol to be the major contributor to 80% of all cirrhosis deaths.

The relationship between alcohol and cirrhosis is generally as follows:

Alcohol is absorbed from the small intestine, and the blood carries it directly into the liver… Continue reading

Inovio Partner Announces Completion Of Phase I DNA Vaccine Study

December 2, 2009 Health News No Comments

Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that its partner Tripep AB of Sweden has completed its phase I clinical study of its ChronVac-C hepatitis C virus DNA vaccine delivered using Inovio’s electroporation technology. The study established the safety and tolerability of this therapy, with vaccine-induced immune responses and transient effects on the serum levels of hepatitis C virus in these chronically infected patients providing proof-of-concept of DNA vaccines delivered using electroporation…

Go to Source… Continue reading

NVHR: New Data Finding Fewer Than 1 In 5 Hepatitis C Patients Receiving Antiviral Therapy Is ‘Wake-Up Call’ For Washington

December 1, 2009 Health News No Comments

New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti-viral therapy in recent years should be a wake-up call that Congress needs to move urgently on bipartisan legislation to support new state-based detection, research, and surveillance efforts, the National Viral Hepatitis Roundtable (NVHR) said today…

Go to Source… Continue reading

Tripep: The ChronVac-C(R) Study Has Been Successfully Completed With Good Safety And Favorable Clinical Data

November 30, 2009 Health News No Comments

All samples from the 12 patients with chronic Hepatitis C genotype 1 treated with Tripep’s therapeutic vaccine ChronVac-C® have now been collected. The treatment was found to be safe, immunogenic and had transient effects on the serum levels of hepatitis C virus. This provides a proof-of-concept for the therapeutic strategy.

Go to Source… Continue reading

Chronic Liver Diseases

November 29, 2009 Liver Disease No Comments

Liver diseases are damaged the function of hapetocytes, it may causes hepatocellular necrosis, fibrosis, and regeneration with nodule formation.

Chronic liver disease in which liver damage slowly by process and persisting over long time.It means it act as slow poison for healthy human body. It is characterized by replacement of liver tissue by fibrous scar tissue as well as regenerative nodules (lumps that occurs as a result of a process inwhich damage tissue is regenerated.It is already to progressive loss of liver function-cirrhosis is due to alcoholism, but in our population it is prohibited by people due religion, poverty… Continue reading

Hepatitis C

November 9, 2009 Liver Disease No Comments

Hepatitis C is a disease of the liver that is caused by the hepatitis C virus, or HCV.

Between 15 to 40 percent of people who get hepatitis C are able to fight off the virus during the early, or acute, stage, usually within six months. Between 60 and 85 percent of patients cannot get rid of the virus and develop a long-term, or chronic, hepatitis C infection. People with chronic hepatitis C will have the disease all their lives unless they are successfully treated with antiviral medicines.

[/caption]

Chronic hepatitis C is a serious condition that… Continue reading

ADS:

Featured Content:

Omni Bio Pharmaceutical, Inc. Hosts Panel On Alpha-1-Antitrypsin ("AAT") At 8th World Congress On Trauma, Shock, Inflammation And Sepsis

March 12, 2010

Omni Bio Pharmaceutical, Inc. (“Omni Bio”) (OTCBB: OMBP) announced that its acting Chief Executive Officer, Dr. Charles A. Dinarello, will moderate a panel at the 8th World Congress on Trauma, Shock, Inflammation and Sepsis (“TSIS”) (http://www.tsis2010.org) in Munich, Germany on Friday, March 12, 2010. The panel on Alpha-1 Antitrypsin (“AAT”) as a Novel Therapeutic in Inflammatory Diseases will feature the following presentations: “Introduction and Background for AAT Safety in Humans and Experimental Models of AAT Protection,” by Dr…

Go to Source… Continue reading

In Cancer Diagnostics, The Profit Is In Test Services

March 12, 2010

The majority of new cancer tests coming to market are proprietary assays with the test services being provided by certified labs opened by the IVD companies that developed the tests. All the major reference labs in North America and Europe are also offering a slew of in-house developed diagnostic tests. This shift is leading to greater profits for those companies offering test services, notes healthcare market research publisher Kalorama Information in its new report “The Worldwide Market for Cancer Diagnostics, 4th Edition.” Test services are not a new business model…

Go to Source… Continue reading

Pelosi: A ‘Climactic Health Care Vote’ As Early As Next Week

March 12, 2010

House Speaker Nancy Pelosi signaled Friday that votes on a health care overhaul could come by the end of next week. Politico: During a Friday meeting with Democratic members, Pelosi told lawmakers to “clear their schedules for next weekend.” She also promised “to stay in session until the landmark vote, people present said afterwards.” Speculation continues that Pelosi doesn’t yet have the votes lined up to pass a reform bill, but that she’s close. “In addition, it looks like House Democrats won’t have to vote directly on a Senate bill they really don’t like. The speaker hasn’t made a final decision, but she told her… Continue reading

Democrats’ Health Bill Plans Could Hinge On Parliamentarian’s Ruling

March 12, 2010

Roll Call: After initially indicating ”the Senate-passed health reform bill must be signed into law before Congress acts on companion reconciliation legislation, the Senate Parliamentarian has acknowledged that there are perhaps ways to draft a reconciliation measure that could move first.” But, if Democrats choose to pursue this approach, “they likely would have to narrow the scope of the reconciliation bill.” The Parliamentarian has noted that moving a broad reconciliation measure without the Senate measure first being signed into law “could create challenging procedural hurdles for Senate Democrats.” This week, Senate GOP leadership received word from the Parliamentarian’s office that… Continue reading

Infant deaths prompt warning on baby slings

March 12, 2010

The government warned Friday that those chic baby slings that hip moms and dads are sporting these days can be dangerous, even deadly for their little ones. Go to Source… Continue reading

Tough Talk About the Health Overhaul, Coming From Democrats

March 12, 2010

There are some harsh words for Democrats trying to overhaul health care in the Washinton Post this morning.
Comprehensive health care has been lost. If it fails, as appears possible, Democrats will face the brunt of the electorate’s reaction. If it passes, however, Democrats will face a far greater calamitous reaction at the polls. Wishing, praying or pretending will not change these outcomes.
Such rhetoric is common coming from Republicans these days, but this is different. The broadside comes in an opinion piece from Patrick H. Caddell and Douglas E. Schoen, pollsters for the last two Democratic presidents, Jimmy Carter and… Continue reading

Kids outgrow growing pains: study

March 12, 2010

Most youngsters grow out of having otherwise unexplained bone and muscle aches known as growing pains, researchers from Israel report.

Of 35 children who originally had growing pains, Dr. Yosef Uziel, at Meir Medical Center in Kfar-Saba, and co-investigators found that 18—or 51 percent—no longer had growing pains 5 years later, when they were about 13 years old.

Fourteen of the 17 who still had growing pains after 5 years said their episodes had decreased and become milder, the researchers report in The Journal of Pediatrics.  Go to Source… Continue reading

Center Aims to Cut Obesity in Black, Latino New Yorkers

March 12, 2010

A $6 million grant from the National Heart, Lung and Blood Institute (NHLBI) has funded the creation of ORBIT: Obesity Related Behavioral Intervention Trials to focus on reducing obesity and obesity-related deaths in New York City’s African-American and Latino communities.

“African-Americans and Latinos have been disproportionately affected by the obesity epidemic, and its related risks for diabetes and heart disease,” says Dr. Mary Charlson, the center’s director, the William T. Foley Distinguished Professor of Medicine at Weill Cornell Medical College, and chief of the Division of Clinical Epidemiology and Evaluative Sciences Research in the Department of Medicine and executive director of… Continue reading

Recent Comments:

  • symptoms of dementia: What's the difference between dementia and Alzheimers? what is the difference? I think my father may be suffering one of these? does anyone know the w...
  • rani: good blog thank 4 the info...
  • JourneyHome: McCarran-Ferguson was originally designed to empower both the federal government and the individual states so that they could act to prevent insurance...
  • Hydro Closet: Hi, I thought I would say you have a wonderful site and rich content. I bookmarked your site and have it in my reader now...looking forward to future ...
  • Allan Ono: Getting more usage from drugs already approved by the FDA for new indications seems like a very good way to expand treatment options without the hyper...